Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Search research articles

Home
Development And Validation Of A Gene Expression-based Breast Cancer Purity Score.

Home
Development And Validation Of A Gene Expression-based Breast Cancer Purity Score.

Related Experiment Video

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Development and validation of a gene expression-based Breast Cancer Purity Score.

Marco Barreca^1,2, Matteo Dugo³, Barbara Galbardi³

¹Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.

NPJ Precision Oncology

|October 25, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

A new 9-gene Breast Cancer Purity Score (BCPS) accurately estimates tumor purity in breast cancer samples. This score helps reduce bias in molecular data analysis and improves cancer prognostication and treatment response prediction.

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Related Experiment Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Area of Science:

Oncology
Genomics
Bioinformatics

Background:

Tumor purity, the proportion of malignant cells, influences molecular profiling of bulk samples.
Variability in tumor purity introduces bias in data analysis and interpretation.
Existing methods for estimating tumor purity lack breast cancer specificity.

Purpose of the Study:

To develop and validate a novel, breast cancer-specific method for estimating tumor purity.
To assess the performance of the new method against existing techniques.
To evaluate the utility of the new score in improving molecular data interpretation and clinical prognostication.

Main Methods:

Interrogation of over 6000 expression profiles from 10 diverse breast cancer datasets.
Development and validation of a 9-gene Breast Cancer Purity Score (BCPS).

Comparative analysis of BCPS against existing tumor purity estimation methods.

Main Results:

The developed BCPS demonstrated superior performance in estimating tumor content compared to existing methods.
Adjusting transcriptomic profiles with BCPS effectively reduced sampling bias and aided data interpretation.
BCPS-estimated tumor purity showed improved prognostication in luminal breast cancer.
BCPS correlated with pathologic complete response in triple-negative breast cancer patients.
BCPS stratified relapse risk in HER2+ residual disease post-neoadjuvant treatment.

Conclusions:

The 9-gene BCPS is a robust and accurate tool for estimating tumor purity in breast cancer.
BCPS facilitates more reliable molecular data analysis and interpretation in large clinical cohorts.
Application of BCPS enhances clinical prognostication and prediction of treatment outcomes in various breast cancer subtypes.